Clinical and Translational Research
Copyright ©The Author(s) 2021.
World J Gastrointest Pathophysiol. Nov 22, 2021; 12(6): 115-133
Published online Nov 22, 2021. doi: 10.4291/wjgp.v12.i6.115
Table 1 Demographic characteristics of the acute pancreatitis patients included in the gene expression analysis study
Parameter
Value [n, %]
AP patient demographicsn = 29
MAP14 (48)
MSAP11 (38)
SAP4 (14)
Age (yr), [median (IQR)]41 (23, 76)
Male (n, %)17 (49)
Female (n, %)12 (51)
AP etiology/risk factor
Biliary (n, %)13 (45)
Alcohol (n, %)13 (45)
ERCP (n, %)1 (3)
Antiretroviral (n, %)2 (7)
Healthy control Demographics
Age (yr), [median (IQR)]36.5 (23, 55)
Male (n, %)3 (50)
Female (n, %)3 (50)
Table 2 List of selected genes and their fold changes in mild, mild acute pancreatitis, moderate, moderately severe acute pancreatitis, and severe acute pancreatitis patients when compared to healthy controls
Gene symbolMAP (n = 7)MSAP (n = 4)SAP (n = 2)
CCL5-2.97-3.76-15.22
CCR81.3338.281172.45
IL10-1.3058.62-1.47
FOXP33.90137.0296.27
IL13-1.9283.6619.53
IL17A1.72116.932.56
IL23A-5.6018.076.57
IL4-1.13108.6436.83
IL51.33192.591.21
NOD1-8.93-14.6264.21
MPO1.3391.7711.8
Table 3 Gene expression levels (fold change 2^-ΔΔCT) for chemokine receptor 8 gene in acute pancreatitis patients.
SeverityMean fold change (2^-ΔΔCT )
MAP D30.8 ± 0.22
MAP D50.9 ± 0.25
MAP D71.0 ± 0.26
MSAP D31386 ± 1372
MSAP D568.0 ± 67
MSAP D7848 ± 846
SAP D31090632 ± 1090631
SAP D51.1, NA
SAP D71.3 ± 0.46